Unlock stock picks and a broker-level newsfeed that powers Wall Street.
209.52
+4.23
+(2.06%)
At close: March 31 at 4:01:21 PM EDT
209.59
+0.07
+(0.03%)
Pre-Market: 6:17:53 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
56,334,000
56,334,000
54,318,000
58,054,000
56,197,000
Cost of Revenue
16,904,000
16,904,000
20,415,000
17,414,000
17,446,000
Gross Profit
39,430,000
39,430,000
33,903,000
40,640,000
38,751,000
Operating Expense
27,536,000
27,536,000
21,146,000
22,523,000
20,827,000
Operating Income
11,894,000
11,894,000
12,757,000
18,117,000
17,924,000
Net Non Operating Interest Income Expense
-2,160,000
-2,160,000
-1,684,000
-2,044,000
-2,384,000
Other Income Expense
-6,018,000
-6,018,000
-4,823,000
-2,596,000
-2,551,000
Pretax Income
3,716,000
3,716,000
6,250,000
13,477,000
12,989,000
Tax Provision
-570,000
-570,000
1,377,000
1,632,000
1,440,000
Net Income Common Stockholders
4,238,000
4,238,000
4,820,000
11,782,000
11,468,000
Diluted NI Available to Com Stockholders
4,238,000
4,238,000
4,820,000
11,782,000
11,468,000
Basic EPS
2.87
2.42
2.73
6.65
6.53
Diluted EPS
2.87
2.39
2.72
6.63
6.45
Basic Average Shares
1,768,750
1,765,256.99
1,768,000
1,771,000
1,768,337.70
Diluted Average Shares
1,773,000
1,773,000
1,773,000
1,778,000
1,777,000
Total Operating Income as Reported
9,137,000
9,137,000
12,757,000
18,117,000
17,924,000
Total Expenses
44,440,000
44,440,000
41,561,000
39,937,000
38,273,000
Net Income from Continuing & Discontinued Operation
4,278,000
4,278,000
4,863,000
11,836,000
11,542,000
Normalized Income
6,472,620
6,472,620
4,976,880
11,966,092
11,587,339
Interest Income
648,000
648,000
540,000
186,000
39,000
Interest Expense
2,808,000
2,808,000
2,224,000
2,230,000
2,423,000
Net Interest Income
-2,160,000
-2,160,000
-1,684,000
-2,044,000
-2,384,000
EBIT
6,524,000
6,524,000
8,474,000
15,707,000
15,412,000
EBITDA
14,910,000
14,910,000
17,172,000
24,174,000
23,933,000
Reconciled Cost of Revenue
16,904,000
16,904,000
20,415,000
17,414,000
17,446,000
Reconciled Depreciation
8,386,000
8,386,000
8,698,000
8,467,000
8,521,000
Net Income from Continuing Operation Net Minority Interest
4,278,000
4,278,000
4,863,000
11,836,000
11,542,000
Total Unusual Items Excluding Goodwill
-2,778,000
-2,778,000
-146,000
-148,000
-51,000
Total Unusual Items
-2,778,000
-2,778,000
-146,000
-148,000
-51,000
Normalized EBITDA
17,688,000
17,688,000
17,318,000
24,322,000
23,984,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-583,380
-583,380
-32,120
-17,908
-5,661
12/31/2021 - 1/2/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRK Merck & Co., Inc.
89.76
+0.59%
JNJ Johnson & Johnson
165.84
+1.30%
PFE Pfizer Inc.
25.34
+0.52%
BMY Bristol-Myers Squibb Company
60.99
+1.62%
LLY Eli Lilly and Company
825.91
+0.41%
AMGN Amgen Inc.
311.55
+1.50%
GILD Gilead Sciences, Inc.
112.05
+0.23%
NVO Novo Nordisk A/S
69.44
+1.82%
GSK GSK plc
38.74
0.00%
AZN AstraZeneca PLC
73.50
-0.39%